Skip to main content

Table 1 Patients’ clinical parameters of the two groups

From: Does incidental durotomy affect clinical outcome in patients with lumbar degenerative diseases after posterior open lumbar interbody fusion? a multicenter observational study

Subgroup

ID group (N = 35)

Non-ID group (N = 371)

P value

Sex

  

0.617

Men

19 (54.3%)

185 (49.9%)

 

Women

16 (45.7%)

186 (50.1%)

 

Age (year)

59.1 ± 6.2

57.3 ± 8.9

0.245

BMI (kg/m2)

25.9 ± 1.6

24.8 ± 2.4

0.008

Smoking

7 (20.0%)

48 (12.9%)

0.411

Diabetes

5 (14.3%)

36 (9.7%)

0.390

Hypertension

10 (28.6%)

86 (23.2%)

0.473

Revision surgery

8 (22.9%)

28 (7.5%)

0.002

ASA score

  

0.034

1

0 (0.0%)

1 (0.3%)

 

2

26 (74.3%)

330 (88.9%)

 

3

9 (25.7%)

40 (10.8%)

 

Operative time (minutes)

174.4 ± 14.2

156.5 ± 26.5

< 0.001

Estimated blood loss (ml)

259.3 ± 44.2

200.2 ± 47.5

< 0.001

Surgical methods

  

0.438

PLIF

19 (54.3%)

176 (47.4%)

 

TLIF

16 (45.7%)

195 (52.6%)

 

Length of hospital stay (day)

9.1 ± 2.1

6.2 ± 1.3

< 0.001

Hospital costs (Yuan)

52721.2 ± 5961.9

47921.7 ± 4465.4

< 0.001

30-day readmission rate

4 (11.4%)

13 (3.5%)

0.049

  1. BMI: body mass index, ASA: American Society of Anesthesiologists, PLIF: Posterior lumbar interbody fusion, TLIF: Transforaminal lumbar interbody fusion